首页 > 最新文献

Journal of Medical Physics最新文献

英文 中文
Detection of Intrafractional Set-Up Errors Using Electronic Portal Imaging Device-based in vivo Dosimetry in Deep-inspiration Breath-hold Irradiation for Left Breast Cancer. 利用基于电子门脉成像装置的体内剂量法检测左乳腺癌深吸气屏气照射中的牵拉内设置错误。
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_74_25
Mai Moritani, Yoshihiro Ueda, Shoki Inui, Hikari Minami, Yuya Nitta, Sayaka Kihara, Asako Hirose, Masaru Isono, Koji Konishi

Aim: This study aimed to clarify the relationship between the results of in vivo dosimetry (IVD) analysis and intrafractional set-up errors (SEs) to determine the criteria for detecting intra-fractional SEs of 3 mm.

Methods: Fifteen patients undergoing deep-inspiration breath-hold (DIBH) irradiation for left breast cancer were included in the study. The prescribed dose and fraction size were 50 Gy for six patients, and 42.56 Gy for nine patients. Visual coaching devices were used to improve the reproducibility of deep inspiration states. For IVD, integrated electronic portal imaging device (EPID) images were obtained using treatment beams. Intra-fractional SEs were detected, and gamma analysis was performed on these images. Receiver-operating characteristic curves were calculated to assess the accuracy of the detection of the intrafractional SEs for each criterion.

Results: The mean values for two-dimensional vectors, absolute Z-direction, and three dimensional (3D) vectors of intra-fractional SEs were 1.9 ± 1.5 mm, 1.8 ± 1.6 mm, and 2.9 ± 1.8 mm, respectively. The mean γ-pass rates in each criterion were 90.6% ± 10.4%, 89.6% ± 10.8%, 92.7% ± 9.7%, 94.8% ± 8.3%, and 94.4% ± 8.3% for 2% 3 mm, 3% 2 mm, 3% 3 mm, 3% 4 mm, and 4% 3 mm, respectively. The correlation coefficients between the SEs in the 3D vector and each γ value ranged from 0.6 to 0.8.

Conclusions: In IVD with EPIDs for DIBH irradiation, the optimal γ-analysis index for intrafractional SEs detection >3 mm is 3% 3 mm.

目的:探讨体内剂量学(IVD)分析结果与术中设置误差(SEs)之间的关系,以确定3 mm术中设置误差的检测标准。方法:选取15例接受深度吸气憋气(DIBH)照射治疗的左乳腺癌患者。6例处方剂量为50 Gy, 9例处方剂量为42.56 Gy。使用视觉指导装置来提高深度灵感状态的再现性。对于IVD,使用治疗光束获得集成电子门静脉成像装置(EPID)图像。检测分数内SEs,并对这些图像进行伽玛分析。计算受者工作特征曲线,以评估每个标准检测作用内se的准确性。结果:分数阶内SEs的二维矢量、绝对z方向和三维矢量的平均值分别为1.9±1.5 mm、1.8±1.6 mm和2.9±1.8 mm。2% 3 mm、3% 2 mm、3% 3 mm、3% 4 mm、4% 3 mm的γ-合格率分别为90.6%±10.4%、89.6%±10.8%、92.7%±9.7%、94.8%±8.3%、94.4%±8.3%。三维矢量se与各γ值的相关系数在0.6 ~ 0.8之间。结论:应用EPIDs进行DIBH辐照的IVD中,显像内SEs检测的最佳γ-分析指数为3% 3mm。
{"title":"Detection of Intrafractional Set-Up Errors Using Electronic Portal Imaging Device-based <i>in vivo</i> Dosimetry in Deep-inspiration Breath-hold Irradiation for Left Breast Cancer.","authors":"Mai Moritani, Yoshihiro Ueda, Shoki Inui, Hikari Minami, Yuya Nitta, Sayaka Kihara, Asako Hirose, Masaru Isono, Koji Konishi","doi":"10.4103/jmp.jmp_74_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_74_25","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to clarify the relationship between the results of <i>in vivo</i> dosimetry (IVD) analysis and intrafractional set-up errors (SEs) to determine the criteria for detecting intra-fractional SEs of 3 mm.</p><p><strong>Methods: </strong>Fifteen patients undergoing deep-inspiration breath-hold (DIBH) irradiation for left breast cancer were included in the study. The prescribed dose and fraction size were 50 Gy for six patients, and 42.56 Gy for nine patients. Visual coaching devices were used to improve the reproducibility of deep inspiration states. For IVD, integrated electronic portal imaging device (EPID) images were obtained using treatment beams. Intra-fractional SEs were detected, and gamma analysis was performed on these images. Receiver-operating characteristic curves were calculated to assess the accuracy of the detection of the intrafractional SEs for each criterion.</p><p><strong>Results: </strong>The mean values for two-dimensional vectors, absolute <i>Z</i>-direction, and three dimensional (3D) vectors of intra-fractional SEs were 1.9 ± 1.5 mm, 1.8 ± 1.6 mm, and 2.9 ± 1.8 mm, respectively. The mean γ-pass rates in each criterion were 90.6% ± 10.4%, 89.6% ± 10.8%, 92.7% ± 9.7%, 94.8% ± 8.3%, and 94.4% ± 8.3% for 2% 3 mm, 3% 2 mm, 3% 3 mm, 3% 4 mm, and 4% 3 mm, respectively. The correlation coefficients between the SEs in the 3D vector and each γ value ranged from 0.6 to 0.8.</p><p><strong>Conclusions: </strong>In IVD with EPIDs for DIBH irradiation, the optimal γ-analysis index for intrafractional SEs detection >3 mm is 3% 3 mm.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"685-692"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing Noise and Improving Image Contrast with a Hybrid Approach to Enhance the Quality of Medical Imaging. 用混合方法降低噪声和提高图像对比度以提高医学成像质量。
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_251_25
Mohammed A Ismael, Mohammed J Alwazzan, Ruaa A Mohammed

Propose: Medical image enhancement is one of the most critical areas in modern medicine, as it helps in disease diagnosis and medical action on the basis of diagnostic accuracy. This paper proposes a new hybrid model having new techniques of noise processing and contrast enhancement for medical images.

Materials and methods: An adaptive Wiener filter can be used to remove noise, the contrast-limited adaptive histogram equalization (CLAHE) algorithm can be used to enhance picture contrast, gamma transforms to correct for illumination, and wavelet transforms may also be employed as another means in order to amplify fine details. For this purpose, the method was first implemented on the retinal images. After that, the same method was long computed tomography (CT) images and finally magnetic resonance imaging (MRI) pictures. To reflect the fractal nature of medical images, 10 retinal images were taken; 10 CT pictures and 10 MRI scans, as a statistical sampling to provide more accurate weighing of the effectiveness in image processing technologies with respect to different medical imaging modalities.

Results: In extreme contrast conditions, by contrasting the results yielded by the proposed method with those of some existing methods, for example, conventional histogram equalization (HE) and CLAHE, considerable enhancement in the image quality could be obtained. The results indicated that our proposed approach outperforms the former approach by suppressing noise but preserving the microstructures of tissues or anatomical structures. It also improves the contrast evenly, providing increased sharpness of the images without loss of vital information and distortion.

Conclusions: This suggested technique equates the value priorities with additional harmonious; this suggests the image is shrewdly for medical purpose. In addition, this allows for translation and better ability to identify more subtlety and specificity tissue, the essence of any medical diagnosis.

医学图像增强是现代医学中最关键的领域之一,它有助于在诊断准确性的基础上进行疾病诊断和医疗行动。本文提出了一种结合噪声处理和对比度增强技术的医学图像混合模型。材料和方法:自适应维纳滤波器可用于去除噪声,对比度限制自适应直方图均衡化(CLAHE)算法可用于增强图像对比度,伽马变换可用于校正照明,小波变换也可用于放大细节。为此,该方法首先在视网膜图像上实现。之后,同样的方法是长时间的计算机断层扫描(CT)图像,最后是磁共振成像(MRI)图像。为反映医学图像的分形特性,选取10幅视网膜图像;10张CT图像和10张MRI扫描,作为统计抽样,以更准确地衡量不同医学成像方式下图像处理技术的有效性。结果:在极端的对比度条件下,通过与现有的一些方法(如传统的直方图均衡化(histogram equalization, HE)和CLAHE)进行对比,可以得到图像质量的显著提高。结果表明,我们提出的方法在抑制噪声的同时保留了组织或解剖结构的微观结构,优于前一种方法。它还可以均匀地提高对比度,在不丢失重要信息和失真的情况下提高图像的清晰度。结论:该建议技术将价值优先级等同于额外的和谐;这表明这幅图像是为医学目的而设计的。此外,这允许翻译和更好地识别更微妙和特异性组织的能力,这是任何医学诊断的本质。
{"title":"Reducing Noise and Improving Image Contrast with a Hybrid Approach to Enhance the Quality of Medical Imaging.","authors":"Mohammed A Ismael, Mohammed J Alwazzan, Ruaa A Mohammed","doi":"10.4103/jmp.jmp_251_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_251_25","url":null,"abstract":"<p><strong>Propose: </strong>Medical image enhancement is one of the most critical areas in modern medicine, as it helps in disease diagnosis and medical action on the basis of diagnostic accuracy. This paper proposes a new hybrid model having new techniques of noise processing and contrast enhancement for medical images.</p><p><strong>Materials and methods: </strong>An adaptive Wiener filter can be used to remove noise, the contrast-limited adaptive histogram equalization (CLAHE) algorithm can be used to enhance picture contrast, gamma transforms to correct for illumination, and wavelet transforms may also be employed as another means in order to amplify fine details. For this purpose, the method was first implemented on the retinal images. After that, the same method was long computed tomography (CT) images and finally magnetic resonance imaging (MRI) pictures. To reflect the fractal nature of medical images, 10 retinal images were taken; 10 CT pictures and 10 MRI scans, as a statistical sampling to provide more accurate weighing of the effectiveness in image processing technologies with respect to different medical imaging modalities.</p><p><strong>Results: </strong>In extreme contrast conditions, by contrasting the results yielded by the proposed method with those of some existing methods, for example, conventional histogram equalization (HE) and CLAHE, considerable enhancement in the image quality could be obtained. The results indicated that our proposed approach outperforms the former approach by suppressing noise but preserving the microstructures of tissues or anatomical structures. It also improves the contrast evenly, providing increased sharpness of the images without loss of vital information and distortion.</p><p><strong>Conclusions: </strong>This suggested technique equates the value priorities with additional harmonious; this suggests the image is shrewdly for medical purpose. In addition, this allows for translation and better ability to identify more subtlety and specificity tissue, the essence of any medical diagnosis.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"751-759"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal Trends in Health-related Quality of Life among Radiotherapy Patients: A Short-term Result of Prospective EORTC QLQ- C30-based Study. 放疗患者健康相关生活质量的纵向趋势:基于EORTC QLQ- c30的前瞻性研究的短期结果
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_134_25
Ainain Yousuf Baba, Abid Ahmad, Obair Yousuf Baba, Misbah Shahid

Purpose: The purpose of the study was to evaluate longitudinal changes in health-related quality of life (HRQoL) among patients undergoing radiotherapy for solid tumors, using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) questionnaire and to identify symptom and function trajectories over time in relation to clinical and demographic parameters.

Materials and methods: In this prospective observational study, 211 adult patients with histologically confirmed solid malignancies (excluding breast cancer) were enrolled at a tertiary oncology center. HRQoL was assessed at four time points: Baseline (T1), end of radiotherapy (T2), 1-month post-treatment (T3), and 6 months' post-treatment (T4), using the validated EORTC QLQ-C30 tool. Statistical analysis included repeated measures analysis of variance and Bonferroni-adjusted post hoc tests.

Results: Global health status improved significantly from T1 (67.0) to T4 (76.0) (P < 0.001). Functional domains, physical, emotional, cognitive, and social functioning, also showed significant improvement (all P < 0.001), whereas role functioning improved modestly (P = 0.009). Symptom scores such as fatigue, pain, nausea/vomiting, and insomnia declined significantly (P < 0.001), whereas dyspnea showed no significant change (P = 0.573). Financial difficulties decreased over time (P < 0.001). Subgroup analyses revealed sex-based variations in symptom burden, with females reporting higher pain and financial strain early post-treatment, and males experiencing greater appetite loss and delayed economic burden.

Conclusion: This study represents preliminary 6-month follow-up data; ongoing surveillance will provide insights into late toxicity and long-term survivorship. Persistent symptoms such as dyspnea highlight the need for targeted supportive interventions. Longitudinal HRQoL monitoring can guide personalized care and survivorship planning.

目的:本研究的目的是利用欧洲癌症研究和治疗组织生活质量问卷(EORTC QLQ-C30)调查问卷,评估接受实体肿瘤放疗的患者健康相关生活质量(HRQoL)的纵向变化,并确定与临床和人口统计学参数相关的症状和功能轨迹。材料和方法:在这项前瞻性观察性研究中,211例组织学证实的实体恶性肿瘤(不包括乳腺癌)成人患者入组于三级肿瘤中心。采用经验证的EORTC QLQ-C30工具,在基线(T1)、放疗结束(T2)、治疗后1个月(T3)和治疗后6个月(T4)四个时间点评估HRQoL。统计分析包括重复测量方差分析和bonferroni调整后的事后检验。结果:从T1(67.0)到T4(76.0),整体健康状况显著改善(P < 0.001)。功能领域,身体、情感、认知和社会功能也有显著改善(均P < 0.001),而角色功能有轻微改善(P = 0.009)。疲劳、疼痛、恶心/呕吐、失眠等症状评分显著下降(P < 0.001),而呼吸困难无显著变化(P = 0.573)。经济困难随着时间的推移而减少(P < 0.001)。亚组分析揭示了症状负担的性别差异,女性在治疗后早期报告更高的疼痛和经济压力,而男性经历更大的食欲减退和延迟的经济负担。结论:本研究代表了初步的6个月随访数据;持续的监测将提供对晚期毒性和长期生存的见解。持续的症状,如呼吸困难,强调需要有针对性的支持性干预措施。HRQoL的纵向监测可以指导个性化护理和生存计划。
{"title":"Longitudinal Trends in Health-related Quality of Life among Radiotherapy Patients: A Short-term Result of Prospective EORTC QLQ- C30-based Study.","authors":"Ainain Yousuf Baba, Abid Ahmad, Obair Yousuf Baba, Misbah Shahid","doi":"10.4103/jmp.jmp_134_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_134_25","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the study was to evaluate longitudinal changes in health-related quality of life (HRQoL) among patients undergoing radiotherapy for solid tumors, using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) questionnaire and to identify symptom and function trajectories over time in relation to clinical and demographic parameters.</p><p><strong>Materials and methods: </strong>In this prospective observational study, 211 adult patients with histologically confirmed solid malignancies (excluding breast cancer) were enrolled at a tertiary oncology center. HRQoL was assessed at four time points: Baseline (T1), end of radiotherapy (T2), 1-month post-treatment (T3), and 6 months' post-treatment (T4), using the validated EORTC QLQ-C30 tool. Statistical analysis included repeated measures analysis of variance and Bonferroni-adjusted <i>post hoc</i> tests.</p><p><strong>Results: </strong>Global health status improved significantly from T1 (67.0) to T4 (76.0) (<i>P</i> < 0.001). Functional domains, physical, emotional, cognitive, and social functioning, also showed significant improvement (all <i>P</i> < 0.001), whereas role functioning improved modestly (<i>P</i> = 0.009). Symptom scores such as fatigue, pain, nausea/vomiting, and insomnia declined significantly (<i>P</i> < 0.001), whereas dyspnea showed no significant change (<i>P</i> = 0.573). Financial difficulties decreased over time (<i>P</i> < 0.001). Subgroup analyses revealed sex-based variations in symptom burden, with females reporting higher pain and financial strain early post-treatment, and males experiencing greater appetite loss and delayed economic burden.</p><p><strong>Conclusion: </strong>This study represents preliminary 6-month follow-up data; ongoing surveillance will provide insights into late toxicity and long-term survivorship. Persistent symptoms such as dyspnea highlight the need for targeted supportive interventions. Longitudinal HRQoL monitoring can guide personalized care and survivorship planning.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"725-730"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of a Monte Carlo Beam Model for 6, 8, and 15 MV Clinical Photon Beams on the Elekta™ Precise Linac. Elekta™精密直线加速器上6、8和15 MV临床光子束蒙特卡罗光束模型的开发和验证
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_96_25
Jjl Smit, Déte Van Eeden, F C P Du Plessis

Introduction: This study investigates a single-source photon beam model and a single source for contamination electrons for Monte Carlo (MC) simulations. Our approach uses a beam characterization model-to-model clinical photon beams for 6, 8, and 15 MV on a linear accelerator. The flattening filter attenuates the photon fluence in the beam model before reaching the secondary collimation accessories. An error function was used to model scatter from these devices. This study aimed to develop a model for clinical X-ray source beams for MC dose calculations for an ElektaTM Precise Linac.

Materials and methods: The photon energy was modeled with the Schiff formula and off-axis beam softening. DOSXYZnrc was used to calculate X-ray dose distributions in water and RW3 solid water phantoms. These distributions were compared to measured EBT3 film or water tank dose data. A gamma (γ) index was calculated to compare the MC and the measured dose. The criteria for the γ-index were 2% dose/2 mm distance-to-agreement. Dose distribution data for square, rectangular, offset, and irregular fields were compared with measurements.

Results: A range of fields for 6, 8, and 15 MV beams was modeled, simulated, and compared to corresponding measured water tank data. Rectangular, small, and medium-sized offset fields met the γ-index criteria of 2%/2 mm.

Conclusion: The beam characterization model performed well against measured data and can be employed for dose verification ranging from regular fields to conformal treatments, as demonstrated by various multi-leaf collimator shapes.

本研究探讨了蒙特卡罗(MC)模拟的单源光子束模型和单源污染电子束模型。我们的方法在线性加速器上使用光束表征模型对模型的临床光子束,分别为6、8和15 MV。在到达二次准直附件之前,压扁滤波器会衰减光束模型中的光子通量。利用误差函数对这些器件的散射进行建模。本研究旨在建立用于ElektaTM精密直线加速器MC剂量计算的临床x射线源光束模型。材料与方法:采用Schiff公式和离轴光束软化法对光子能量进行建模。用DOSXYZnrc计算x射线在水中和RW3固体水幻影中的剂量分布。将这些分布与测量的EBT3膜或水箱剂量数据进行比较。计算γ (γ)指数来比较MC和测量剂量。γ-指数的判定标准为2%剂量/ 2mm距离。将方形、矩形、偏置和不规则场的剂量分布数据与测量值进行比较。结果:对6、8和15 MV光束的范围进行了建模、模拟,并与相应的水箱测量数据进行了比较。矩形、小、中型偏移场均满足2%/2 mm的γ-指数标准。结论:该光束表征模型与实测数据吻合良好,可用于从规则场到适形处理的剂量验证。
{"title":"Development and Validation of a Monte Carlo Beam Model for 6, 8, and 15 MV Clinical Photon Beams on the Elekta™ Precise Linac.","authors":"Jjl Smit, Déte Van Eeden, F C P Du Plessis","doi":"10.4103/jmp.jmp_96_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_96_25","url":null,"abstract":"<p><strong>Introduction: </strong>This study investigates a single-source photon beam model and a single source for contamination electrons for Monte Carlo (MC) simulations. Our approach uses a beam characterization model-to-model clinical photon beams for 6, 8, and 15 MV on a linear accelerator. The flattening filter attenuates the photon fluence in the beam model before reaching the secondary collimation accessories. An error function was used to model scatter from these devices. This study aimed to develop a model for clinical X-ray source beams for MC dose calculations for an Elekta<sup>TM</sup> Precise Linac.</p><p><strong>Materials and methods: </strong>The photon energy was modeled with the Schiff formula and off-axis beam softening. DOSXYZnrc was used to calculate X-ray dose distributions in water and RW3 solid water phantoms. These distributions were compared to measured EBT3 film or water tank dose data. A gamma (γ) index was calculated to compare the MC and the measured dose. The criteria for the γ-index were 2% dose/2 mm distance-to-agreement. Dose distribution data for square, rectangular, offset, and irregular fields were compared with measurements.</p><p><strong>Results: </strong>A range of fields for 6, 8, and 15 MV beams was modeled, simulated, and compared to corresponding measured water tank data. Rectangular, small, and medium-sized offset fields met the γ-index criteria of 2%/2 mm.</p><p><strong>Conclusion: </strong>The beam characterization model performed well against measured data and can be employed for dose verification ranging from regular fields to conformal treatments, as demonstrated by various multi-leaf collimator shapes.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"663-674"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of an Additional Shielding Sheet for Reducing Radiation Exposure to Patients and Medical Staff during Interventional Radiology. 在介入放射学中,附加屏蔽片对减少患者和医务人员辐射暴露的有用性。
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_199_25
Kang Nam Baek, Sungchul Kim

Background: Interventional radiology (IR) procedures often require prolonged fluoroscopic imaging, resulting in substantial radiation exposure to both patients and medical staff. Although conventional protective devices are widely used, the scattered radiation beneath the procedural table remains inadequately shielded.

Materials and methods: An additional shielding sheet, fabricated from a discarded 0.25 mmPb lead apron, was developed to block the open space between the interventional table and lead curtain. Phantom-based simulations of bronchial artery embolization (BAE) and transarterial chemoembolization (TACE) have been performed. Optically stimulated luminescence dosimeters were used to measure the radiation doses in the radiosensitive organs of the patient and operator phantoms, both with and without an additional shielding sheet. This study also evaluated dose reduction in the presence or absence of personal protective devices (PPD). Statistical significance was determined using the Wilcoxon signed-rank test (P < 0.05).

Results: When an additional shielding sheet was used, the patient dose was significantly reduced by 20.5% and 20.6% during BAE and TACE, respectively (both P < 0.05). For operators, dose reductions were 68.1% and 43.3% during BAE and TACE with PPD, respectively. Without PPD, the dose was also significantly reduced in both BAE and TACE procedures (P < 0.05).

Conclusions: Additional shielding sheets significantly decreased radiation exposure in both patients and operators during IR procedures. This simple and cost-effective device complements existing shielding tools and enhances radiation safety in clinical practice.

背景:介入放射学(IR)程序通常需要长时间的透视成像,导致大量的辐射暴露给患者和医务人员。虽然传统的防护装置被广泛使用,但手术台面下的散射辐射仍然没有得到充分的屏蔽。材料和方法:使用废弃的0.25 mmPb铅胶圈制作额外的屏蔽片,以阻挡介入台和铅幕之间的开放空间。支气管动脉栓塞(BAE)和经动脉化疗栓塞(TACE)的模拟已经完成。光激发发光剂量计被用来测量病人和操作员幻影的辐射敏感器官的辐射剂量,有和没有额外的屏蔽片。本研究还评估了在有或没有个人防护装置(PPD)的情况下剂量的减少。采用Wilcoxon符号秩检验确定统计学意义(P < 0.05)。结果:在BAE和TACE期间,当额外使用屏蔽片时,患者剂量分别显著降低20.5%和20.6% (P均< 0.05)。对于操作者来说,在BAE和TACE合并PPD期间,剂量分别减少了68.1%和43.3%。在不加PPD的情况下,BAE和TACE治疗的剂量也显著降低(P < 0.05)。结论:在IR过程中,额外的屏蔽片显著降低了患者和操作人员的辐射暴露。这种简单而经济的设备补充了现有的屏蔽工具,提高了临床实践中的辐射安全性。
{"title":"Usefulness of an Additional Shielding Sheet for Reducing Radiation Exposure to Patients and Medical Staff during Interventional Radiology.","authors":"Kang Nam Baek, Sungchul Kim","doi":"10.4103/jmp.jmp_199_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_199_25","url":null,"abstract":"<p><strong>Background: </strong>Interventional radiology (IR) procedures often require prolonged fluoroscopic imaging, resulting in substantial radiation exposure to both patients and medical staff. Although conventional protective devices are widely used, the scattered radiation beneath the procedural table remains inadequately shielded.</p><p><strong>Materials and methods: </strong>An additional shielding sheet, fabricated from a discarded 0.25 mmPb lead apron, was developed to block the open space between the interventional table and lead curtain. Phantom-based simulations of bronchial artery embolization (BAE) and transarterial chemoembolization (TACE) have been performed. Optically stimulated luminescence dosimeters were used to measure the radiation doses in the radiosensitive organs of the patient and operator phantoms, both with and without an additional shielding sheet. This study also evaluated dose reduction in the presence or absence of personal protective devices (PPD). Statistical significance was determined using the Wilcoxon signed-rank test (<i>P</i> < 0.05).</p><p><strong>Results: </strong>When an additional shielding sheet was used, the patient dose was significantly reduced by 20.5% and 20.6% during BAE and TACE, respectively (both <i>P</i> < 0.05). For operators, dose reductions were 68.1% and 43.3% during BAE and TACE with PPD, respectively. Without PPD, the dose was also significantly reduced in both BAE and TACE procedures (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>Additional shielding sheets significantly decreased radiation exposure in both patients and operators during IR procedures. This simple and cost-effective device complements existing shielding tools and enhances radiation safety in clinical practice.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"790-794"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Automated System for Analysis and Classification of Kinetic Curve on Dynamic Contrast-enhanced Magnetic Resonance Imaging Breast Lesion. 乳腺动态增强磁共振成像病灶动力学曲线自动分析与分类系统。
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_105_25
Maryam M Hussein, Tara Farooq Kareem, Luma J Satoory

Background: Breast cancer is one of the most common cancers affecting women worldwide. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a highly sensitive technique for the diagnosis of breast cancer, providing comprehensive kinetic analysis of lesions.

Objective: This study aimed to develop an automated method for classifying kinetic curves derived from DCE-MRI into three types - persistent (Type I), plateau (Type II), and washout (Type III) - using a support vector machine (SVM) classifier.

Methods: DCE-MRI scans from 41 histopathologically confirmed breast lesions were analyzed. Region of interest were manually selected by an expert radiologist on the most enhancing solid areas. Kinetic features, including initial enhancement (E_Initial), early signal enhancement ratio, peak enhancement (E_Peak), and four gradient-based slope features, were extracted. A SVM classifier was trained on these features, and performance was evaluated using accuracy, sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve (AUC) to investigate the efficacy in distinguishing between the kinetic curve for each suspicious breast lesion.

Results: The performance of the classification procedure employing the kinetic features with (P < 0.001) was evaluated by means of several measures, including accuracy, sensitivity, specificity, 97.56%, 96.49%, 100%, 100%, and 97.62%, respectively. The results achieved a higher area under the ROC curve (AUC) of 100%.

Conclusion: To diagnose breast lesions, DCE-MRI scans offer an important information, such as kinetic analysis, which is a useful and irreplaceable component of breast diagnostics. This approach may reduce unnecessary biopsies and improve diagnostic efficiency.

背景:乳腺癌是影响全世界妇女的最常见的癌症之一。动态对比增强磁共振成像(DCE-MRI)是一种高度敏感的乳腺癌诊断技术,提供了病变的全面动力学分析。目的:本研究旨在开发一种基于支持向量机(SVM)分类器的自动方法,将DCE-MRI得出的动力学曲线分为三种类型——持续型(I型)、平台型(II型)和冲刷型(III型)。方法:对41例经组织病理学证实的乳腺病变进行DCE-MRI扫描分析。感兴趣的区域由放射科专家在最增强的固体区域上手动选择。提取了初始增强(E_Initial)、早期信号增强比、峰值增强(E_Peak)和4个基于梯度的坡度特征等动力学特征。基于这些特征训练SVM分类器,并使用准确性、灵敏度、特异性和受试者工作特征曲线下面积(ROC曲线下面积)来评估其性能,以研究区分每个可疑乳腺病变的动力学曲线的有效性。结果:采用动力学特征(P < 0.001)的分类方法的准确性、敏感性、特异性分别为97.56%、96.49%、100%、100%和97.62%。结果获得了较高的ROC曲线下面积(AUC)为100%。结论:DCE-MRI扫描为乳腺病变诊断提供了动力学分析等重要信息,是乳腺诊断中有用且不可替代的组成部分。这种方法可以减少不必要的活检,提高诊断效率。
{"title":"An Automated System for Analysis and Classification of Kinetic Curve on Dynamic Contrast-enhanced Magnetic Resonance Imaging Breast Lesion.","authors":"Maryam M Hussein, Tara Farooq Kareem, Luma J Satoory","doi":"10.4103/jmp.jmp_105_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_105_25","url":null,"abstract":"<p><strong>Background: </strong>Breast cancer is one of the most common cancers affecting women worldwide. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a highly sensitive technique for the diagnosis of breast cancer, providing comprehensive kinetic analysis of lesions.</p><p><strong>Objective: </strong>This study aimed to develop an automated method for classifying kinetic curves derived from DCE-MRI into three types - persistent (Type I), plateau (Type II), and washout (Type III) - using a support vector machine (SVM) classifier.</p><p><strong>Methods: </strong>DCE-MRI scans from 41 histopathologically confirmed breast lesions were analyzed. Region of interest were manually selected by an expert radiologist on the most enhancing solid areas. Kinetic features, including initial enhancement (E_Initial), early signal enhancement ratio, peak enhancement (E_Peak), and four gradient-based slope features, were extracted. A SVM classifier was trained on these features, and performance was evaluated using accuracy, sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve (AUC) to investigate the efficacy in distinguishing between the kinetic curve for each suspicious breast lesion.</p><p><strong>Results: </strong>The performance of the classification procedure employing the kinetic features with (<i>P</i> < 0.001) was evaluated by means of several measures, including accuracy, sensitivity, specificity, 97.56%, 96.49%, 100%, 100%, and 97.62%, respectively. The results achieved a higher area under the ROC curve (AUC) of 100%.</p><p><strong>Conclusion: </strong>To diagnose breast lesions, DCE-MRI scans offer an important information, such as kinetic analysis, which is a useful and irreplaceable component of breast diagnostics. This approach may reduce unnecessary biopsies and improve diagnostic efficiency.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"760-765"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric Validation of Treatment Plan Interchangeability between Factory Beam-matched Varian TrueBeam and Clinac Linear Accelerators for Volumetric Modulated Arc Therapy and IMRT Delivery. 剂量学验证在工厂光束匹配瓦里安TrueBeam和临床线性加速器之间的治疗计划互换性,用于体积调制电弧治疗和IMRT输送。
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_172_25
Mukesh Kumar Zope, Deepali Patil, Seema Devi, Devraj Singh

Purpose: The purpose of this study was to assess the dosimetric consistency and clinical interchangeability of treatment plans between factory beam-matched Varian TrueBeam SVC and Clinac iX linear accelerators across various anatomical locations.

Materials and methods: Eighty clinical plans were analyzed, including 40 intensity modulated radiotherapy (IMRT) plans (20 for cervix and 20 for head and neck) and 40 volumetric modulated arc therapy (VMAT) plans (20 for breast and 20 for urinary bladder). Both linacs were independently commissioned per AAPM-106 protocols. Plans were recalculated on the alternate machine and compared statistically. Patient-specific QA was performed using ArcCHECK with 3%/2 mm gamma criteria. Transferable fractions were estimated using ICRU-50 (±5%) and AAPM TG-40 (±2%) guidelines to determine fractions safely deliverable without re-planning.

Results: Beam commissioning showed excellent agreement within ±1% for all dosimetric parameters. Head and neck IMRT had minimal differences (D95%: -0.26%, P < 0.001) and the highest transferability (median 39%, 10-14 fractions). Breast VMAT achieved consistent organ-at-risk sparing with moderate transferability (median 19%, 2-4 fractions). Urinary bladder VMAT displayed acceptable transferability (median 29%, 7-11 fractions). Cervical IMRT showed systematic dose increases on TrueBeam (planning target volume D95%: +1.57%, P = 0.012) with limited transferability (median 14%, 1-2 fractions). All plans exceeded gamma passing rates of 97.3%, with VMAT demonstrating superior consistency over IMRT (99.1% vs. 97.3-98.6%).

Conclusions: Linear accelerators that are beam-matched in factories provide safe interchangeability of treatment plans for the majority of clinical scenarios, with VMAT showing improved consistency over IMRT due to continuous arc delivery averaging out minor machine-specific variations in multileaf collimator positioning and dose rate.

目的:本研究的目的是评估工厂光束匹配Varian TrueBeam SVC和Clinac iX线性加速器在不同解剖位置之间治疗方案的剂量一致性和临床互换性。材料与方法:对80个临床方案进行分析,包括40个调强放疗(IMRT)方案(宫颈20个,头颈部20个)和40个体积调制弧线治疗(VMAT)方案(乳腺20个,膀胱20个)。根据AAPM-106协议,两台直线机都是独立调试的。在备用机器上重新计算计划并进行统计比较。采用ArcCHECK进行患者特异性QA,标准为3%/ 2mm。使用ICRU-50(±5%)和AAPM TG-40(±2%)指南估计可转移分数,以确定无需重新规划即可安全交付的分数。结果:光束调试对所有剂量学参数的一致性在±1%以内。头颈部IMRT差异最小(D95%: -0.26%, P < 0.001),可转移性最高(中位数39%,10-14分)。乳腺VMAT获得了一致的有风险的器官保留,具有中等的可转移性(中位数19%,2-4分)。膀胱VMAT显示可接受的可转移性(中位数29%,7-11分)。宫颈IMRT显示TrueBeam的系统剂量增加(计划靶体积D95%: +1.57%, P = 0.012),可转移性有限(中位数14%,1-2个分数)。所有方案的伽玛通过率均超过97.3%,VMAT表现出优于IMRT的一致性(99.1%比93.3% -98.6%)。结论:工厂中光束匹配的线性加速器为大多数临床场景提供了安全的治疗方案互换性,VMAT由于连续电弧输送平均了多叶准直器定位和剂量率的微小机器特异性变化,因此比IMRT显示出更高的一致性。
{"title":"Dosimetric Validation of Treatment Plan Interchangeability between Factory Beam-matched Varian TrueBeam and Clinac Linear Accelerators for Volumetric Modulated Arc Therapy and IMRT Delivery.","authors":"Mukesh Kumar Zope, Deepali Patil, Seema Devi, Devraj Singh","doi":"10.4103/jmp.jmp_172_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_172_25","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to assess the dosimetric consistency and clinical interchangeability of treatment plans between factory beam-matched Varian TrueBeam SVC and Clinac iX linear accelerators across various anatomical locations.</p><p><strong>Materials and methods: </strong>Eighty clinical plans were analyzed, including 40 intensity modulated radiotherapy (IMRT) plans (20 for cervix and 20 for head and neck) and 40 volumetric modulated arc therapy (VMAT) plans (20 for breast and 20 for urinary bladder). Both linacs were independently commissioned per AAPM-106 protocols. Plans were recalculated on the alternate machine and compared statistically. Patient-specific QA was performed using ArcCHECK with 3%/2 mm gamma criteria. Transferable fractions were estimated using ICRU-50 (±5%) and AAPM TG-40 (±2%) guidelines to determine fractions safely deliverable without re-planning.</p><p><strong>Results: </strong>Beam commissioning showed excellent agreement within ±1% for all dosimetric parameters. Head and neck IMRT had minimal differences (D95%: -0.26%, <i>P</i> < 0.001) and the highest transferability (median 39%, 10-14 fractions). Breast VMAT achieved consistent organ-at-risk sparing with moderate transferability (median 19%, 2-4 fractions). Urinary bladder VMAT displayed acceptable transferability (median 29%, 7-11 fractions). Cervical IMRT showed systematic dose increases on TrueBeam (planning target volume D95%: +1.57%, <i>P</i> = 0.012) with limited transferability (median 14%, 1-2 fractions). All plans exceeded gamma passing rates of 97.3%, with VMAT demonstrating superior consistency over IMRT (99.1% vs. 97.3-98.6%).</p><p><strong>Conclusions: </strong>Linear accelerators that are beam-matched in factories provide safe interchangeability of treatment plans for the majority of clinical scenarios, with VMAT showing improved consistency over IMRT due to continuous arc delivery averaging out minor machine-specific variations in multileaf collimator positioning and dose rate.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"698-708"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Dosiomics Features and Dosimetric Parameters for Detecting Variations in Dose Distribution in Breast Cancer Radiotherapy. 检测乳腺癌放疗剂量分布变化的剂量组学特征和剂量学参数的比较。
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_145_25
Marziyeh Mirzaeiyan, Ali Akhavan, Parvaneh Shokrani, Zahra Sharifonnasabi, Mahnaz Etehadtavakol

Background: This study aimed to investigate and compare the ability of dosiomics features (DFs) and dosimetric parameters (DPs) in detecting variations in dose distribution.

Materials and methods: This research included 15 patients with early-stage breast cancer who had previously undergone radiotherapy using three-dimensional (3D) conformal radiotherapy technique. Four treatment plans are created by different users for each patient. DPs such as D 1%(%), D 5%(%), and …, up to D 100%(%) were analyzed for each region of interest, and DFs were extracted from each plan using 3D-Slicer software. The coefficient of variation (CV) was used to measure the ability of each DFs or DPs to identify differences in dose distribution. CVs were calculated for intrapatient (across four plans) and interpatient (across one plan for all patients) comparisons.

Results: Results showed that the planning target volume (PTV) and heart had the highest CV values in the gray level size zone matrix group (1.05, 0.68). The PTV showed the highest CV for SZM-large area low gray level emphasis, the lung for SZM-Small area low gray level emphasis, and the heart for SZM-size zone nonuniformity. For the D 20%(%) parameter, the heart had the highest CV, followed by the lung and PTV, with CVs of 0.7, 0.56, and 0.51, respectively.

Conclusion: The findings suggest that DFs are more effective than DPs in differentiating between dose distributions. These features could play a key role in future radiotherapy plan evaluations with further study.

背景:本研究旨在探讨和比较剂量组学特征(DFs)和剂量学参数(DPs)检测剂量分布变化的能力。材料与方法:本研究纳入15例早期乳腺癌患者,均曾接受过三维适形放疗技术。四个治疗方案由不同的用户为每个病人创建。分析每个感兴趣区域的DPs,如d1%(%)、d5%(%)和…,直至d100%(%),并使用3D-Slicer软件从每个平面图中提取DFs。变异系数(CV)用于衡量每个DFs或DPs识别剂量分布差异的能力。计算了患者内(跨四个计划)和患者间(跨一个计划,所有患者)比较的cv。结果:结果显示,规划目标体积(PTV)和心脏在灰度大小区矩阵组的CV值最高(1.05,0.68)。PTV的CV值在szm -大面积低灰度强调区最高,肺为szm -小面积低灰度强调区,心脏为szm -大小区不均匀区。对于d20%(%)参数,心脏的CV最高,其次是肺和PTV, CV分别为0.7、0.56和0.51。结论:DFs在区分剂量分布方面比DPs更有效。这些特征对今后放疗方案的评价具有重要意义。
{"title":"Comparison of Dosiomics Features and Dosimetric Parameters for Detecting Variations in Dose Distribution in Breast Cancer Radiotherapy.","authors":"Marziyeh Mirzaeiyan, Ali Akhavan, Parvaneh Shokrani, Zahra Sharifonnasabi, Mahnaz Etehadtavakol","doi":"10.4103/jmp.jmp_145_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_145_25","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate and compare the ability of dosiomics features (DFs) and dosimetric parameters (DPs) in detecting variations in dose distribution.</p><p><strong>Materials and methods: </strong>This research included 15 patients with early-stage breast cancer who had previously undergone radiotherapy using three-dimensional (3D) conformal radiotherapy technique. Four treatment plans are created by different users for each patient. DPs such as <i>D</i> <sub>1%</sub>(%), <i>D</i> <sub>5%</sub>(%), and …, up to <i>D</i> <sub>100%</sub>(%) were analyzed for each region of interest, and DFs were extracted from each plan using 3D-Slicer software. The coefficient of variation (CV) was used to measure the ability of each DFs or DPs to identify differences in dose distribution. CVs were calculated for intrapatient (across four plans) and interpatient (across one plan for all patients) comparisons.</p><p><strong>Results: </strong>Results showed that the planning target volume (PTV) and heart had the highest CV values in the gray level size zone matrix group (1.05, 0.68). The PTV showed the highest CV for SZM-large area low gray level emphasis, the lung for SZM-Small area low gray level emphasis, and the heart for SZM-size zone nonuniformity. For the <i>D</i> <sub>20%</sub>(%) parameter, the heart had the highest CV, followed by the lung and PTV, with CVs of 0.7, 0.56, and 0.51, respectively.</p><p><strong>Conclusion: </strong>The findings suggest that DFs are more effective than DPs in differentiating between dose distributions. These features could play a key role in future radiotherapy plan evaluations with further study.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"650-656"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast Glandularity Distribution and Refining the Mean Glandular Dose Estimates in Digital Mammography. 数字乳房x线照相术中乳腺腺体分布和细化平均腺体剂量估计。
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_142_25
Mirjeta Mediji Arifi, Mimoza Ristova

Background: In mammography, radiation dose is typically expressed as the mean glandular dose (MGD), which represents the dose delivered to the glandular tissue of the breast.

Materials and methods: This study compares MGD estimates obtained using three different methodologies: (I) MGD-Dance-Laboratory for Individualized Breast Radiodensity Assessment (LIBRA) - Calculated manually for each patient using Dance's formula, incorporating mammographic breast density values derived from the LIBRA application, thereby replacing Dance's standard glandularity assumption with image-specific values; (II) MGD-Dance - Calculated using Dance's formula with the conventional assumption of 50% glandularity; (III) MGD-Displayed - Extracted directly from the Digital Imaging and Communication in Medicine header of each mammogram.

Results: A total of 688 anonymized mammograms from 172 women undergoing routine screening were analyzed, with complete technical and patient-related data. The mean MGD values obtained by the three methods were: MGD-Dance-LIBRA: 2.97 mGy; MGD-Dance: 2.78 mGy; and MGD-Displayed: 2.81 mGy. The average glandularity across the dataset was estimated at 14%. A strong correlation was observed between MGD-Dance and MGD-Dance-LIBRA values (R² =0.9865). The refined dose estimation using image-specific glandularity from LIBRA consistently produced slightly higher values compared to the standard Dance method, highlighting the impact of the commonly assumed 50% glandularity, which overestimates the true average density.

Conclusions: Incorporating individualized breast density estimates from the LIBRA application into Dance's formula provides a more refined and accurate method for calculating MGD in digital mammography.

背景:在乳房x线摄影中,辐射剂量通常表示为平均腺剂量(MGD),它代表了传递到乳腺腺组织的剂量。材料和方法:本研究比较了使用三种不同方法获得的MGD估估值:(I) MGD-Dance-个体化乳房放射密度评估实验室(LIBRA) -使用Dance的公式为每位患者手动计算,结合从LIBRA应用中获得的乳房x线摄影乳房密度值,从而用图像特异性值取代Dance的标准腺体假设;(II) MGD-Dance -使用Dance的公式计算,传统假设为50%的腺体;(III) mgd显示-直接从每个乳房x光片的数字成像和医学通信标题中提取。结果:对172名接受常规筛查的妇女的688张匿名乳房x光片进行了分析,具有完整的技术和患者相关数据。三种方法测得的平均MGD值为:MGD- dance - libra: 2.97 mGy;MGD-Dance: 2.78 mGy;mgd显示:2.81 mGy。整个数据集的平均腺密度估计为14%。MGD-Dance值与MGD-Dance- libra值有很强的相关性(R²=0.9865)。与标准Dance方法相比,使用来自LIBRA的图像特异性腺体的精细剂量估计始终产生略高的值,突出了通常假设的50%腺体的影响,这高估了真实平均密度。结论:将LIBRA应用的个体化乳腺密度估计纳入Dance的公式,为数字乳房x线摄影中计算MGD提供了更精细和准确的方法。
{"title":"Breast Glandularity Distribution and Refining the Mean Glandular Dose Estimates in Digital Mammography.","authors":"Mirjeta Mediji Arifi, Mimoza Ristova","doi":"10.4103/jmp.jmp_142_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_142_25","url":null,"abstract":"<p><strong>Background: </strong>In mammography, radiation dose is typically expressed as the mean glandular dose (MGD), which represents the dose delivered to the glandular tissue of the breast.</p><p><strong>Materials and methods: </strong>This study compares MGD estimates obtained using three different methodologies: (I) MGD-Dance-Laboratory for Individualized Breast Radiodensity Assessment (LIBRA) - Calculated manually for each patient using Dance's formula, incorporating mammographic breast density values derived from the LIBRA application, thereby replacing Dance's standard glandularity assumption with image-specific values; (II) MGD-Dance - Calculated using Dance's formula with the conventional assumption of 50% glandularity; (III) MGD-Displayed - Extracted directly from the Digital Imaging and Communication in Medicine header of each mammogram.</p><p><strong>Results: </strong>A total of 688 anonymized mammograms from 172 women undergoing routine screening were analyzed, with complete technical and patient-related data. The mean MGD values obtained by the three methods were: MGD-Dance-LIBRA: 2.97 mGy; MGD-Dance: 2.78 mGy; and MGD-Displayed: 2.81 mGy. The average glandularity across the dataset was estimated at 14%. A strong correlation was observed between MGD-Dance and MGD-Dance-LIBRA values (<i>R</i>² =0.9865). The refined dose estimation using image-specific glandularity from LIBRA consistently produced slightly higher values compared to the standard Dance method, highlighting the impact of the commonly assumed 50% glandularity, which overestimates the true average density.</p><p><strong>Conclusions: </strong>Incorporating individualized breast density estimates from the LIBRA application into Dance's formula provides a more refined and accurate method for calculating MGD in digital mammography.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"795-801"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Interfraction Dose Discrepancies in Organs at Risk, Clinical Target Volume, and Points A and B in Computed Tomography-based High-dose-rate Intracavitary Brachytherapy for Cervical Cancer Patients. 基于ct的宫颈癌患者高剂量率腔内近距离放射治疗中危险器官、临床靶体积、A点和B点的介入剂量差异评价
IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-01 Epub Date: 2025-12-31 DOI: 10.4103/jmp.jmp_162_25
Vishwadeep Mishra, Laxman Pandey, Ankita Pandey, Rachita Chatterjee, Sudeep Chanda, Archana Pandey

Aim: Brachytherapy is an integral part of the management of carcinoma cervix. High-dose-rate intracavitary brachytherapy (HDR ICBT) is often delivered after external beam radiotherapy (EBRT) in more than one session. The uncertainties may arise due to variations in anatomy and applicator position during each session, which may impact dose distribution to the clinical target volume (CTV) and normal organs. This study aims to quantify interfraction dose variations in HDR ICBT for cervical cancer patients using computed tomography-based planning.

Materials and methods: In this retrospective study, 30 patients with carcinoma cervix of the International Federation of Gynecology and Obstetrics stage IB2 to IVA after EBRT were included in the study. Total dose for ICBT was 21 Gy delivered in 3 weekly fractions. Doses to CTV, Point A, Point B, and normal organs (rectum, bladder, and sigmoid colon) were recorded in each session. Statistical analysis was conducted using the Chi-square test to compare dose variations between fractions, with a significance level set at P < 0.05.

Results: Mean dose received by 90% of the CTV was 5.92 Gy, 5.77 Gy, and 6.05 Gy for the first, second, and third fractions, respectively. Doses to 0.1 cc of bladder were 8.02 Gy, 7.17 Gy, and 7.51 Gy across fractions, whereas for 1 cc, doses were 6.17 Gy, 5.88 Gy, and 6.15 Gy, respectively. For 1 cc of rectum, doses were 5.60 Gy, 4.90 Gy, and 5.23 Gy, and for 2 cc, 5.17 Gy, 4.34 Gy, and 4.71 Gy, respectively, for three fractions. Sigmoid doses had relatively stable dose variation.

Conclusion: Bladder, rectal, and sigmoid doses varied considerably across fractions, emphasizing the need for strict organ preparation protocols and adaptive dose monitoring.

目的:近距离放射治疗是宫颈癌治疗的重要组成部分。高剂量率腔内近距离放射治疗(HDR ICBT)通常在体外放射治疗(EBRT)后进行一次以上的治疗。不确定性可能是由于解剖结构和每次施药时施药器位置的变化而产生的,这可能影响临床靶体积(CTV)和正常器官的剂量分布。本研究旨在利用基于计算机断层扫描的计划,量化宫颈癌患者HDR ICBT的相互作用剂量变化。材料与方法:本回顾性研究纳入30例国际妇产科联合会IB2 ~ IVA期宫颈癌EBRT患者。ICBT总剂量为21 Gy,分3周给药。记录每次治疗对CTV、A点、B点和正常器官(直肠、膀胱和乙状结肠)的剂量。采用卡方检验比较各组间剂量变化,P < 0.05为显著性水平。结果:90% CTV的平均剂量分别为5.92 Gy、5.77 Gy、6.05 Gy。0.1 cc膀胱的剂量分别为8.02 Gy、7.17 Gy和7.51 Gy,而1 cc膀胱的剂量分别为6.17 Gy、5.88 Gy和6.15 Gy。对于1 cc直肠,剂量分别为5.60 Gy, 4.90 Gy和5.23 Gy,对于2 cc,剂量分别为5.17 Gy, 4.34 Gy和4.71 Gy。乙状元剂量变化相对稳定。结论:膀胱、直肠和乙状结肠剂量在不同部位差异很大,强调需要严格的器官准备方案和适应性剂量监测。
{"title":"Evaluation of Interfraction Dose Discrepancies in Organs at Risk, Clinical Target Volume, and Points A and B in Computed Tomography-based High-dose-rate Intracavitary Brachytherapy for Cervical Cancer Patients.","authors":"Vishwadeep Mishra, Laxman Pandey, Ankita Pandey, Rachita Chatterjee, Sudeep Chanda, Archana Pandey","doi":"10.4103/jmp.jmp_162_25","DOIUrl":"https://doi.org/10.4103/jmp.jmp_162_25","url":null,"abstract":"<p><strong>Aim: </strong>Brachytherapy is an integral part of the management of carcinoma cervix. High-dose-rate intracavitary brachytherapy (HDR ICBT) is often delivered after external beam radiotherapy (EBRT) in more than one session. The uncertainties may arise due to variations in anatomy and applicator position during each session, which may impact dose distribution to the clinical target volume (CTV) and normal organs. This study aims to quantify interfraction dose variations in HDR ICBT for cervical cancer patients using computed tomography-based planning.</p><p><strong>Materials and methods: </strong>In this retrospective study, 30 patients with carcinoma cervix of the International Federation of Gynecology and Obstetrics stage IB2 to IVA after EBRT were included in the study. Total dose for ICBT was 21 Gy delivered in 3 weekly fractions. Doses to CTV, Point A, Point B, and normal organs (rectum, bladder, and sigmoid colon) were recorded in each session. Statistical analysis was conducted using the Chi-square test to compare dose variations between fractions, with a significance level set at <i>P</i> < 0.05.</p><p><strong>Results: </strong>Mean dose received by 90% of the CTV was 5.92 Gy, 5.77 Gy, and 6.05 Gy for the first, second, and third fractions, respectively. Doses to 0.1 cc of bladder were 8.02 Gy, 7.17 Gy, and 7.51 Gy across fractions, whereas for 1 cc, doses were 6.17 Gy, 5.88 Gy, and 6.15 Gy, respectively. For 1 cc of rectum, doses were 5.60 Gy, 4.90 Gy, and 5.23 Gy, and for 2 cc, 5.17 Gy, 4.34 Gy, and 4.71 Gy, respectively, for three fractions. Sigmoid doses had relatively stable dose variation.</p><p><strong>Conclusion: </strong>Bladder, rectal, and sigmoid doses varied considerably across fractions, emphasizing the need for strict organ preparation protocols and adaptive dose monitoring.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"50 4","pages":"709-713"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146183345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Medical Physics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1